Crossmark

Occurrence and predictors of adverse events associated with Linezolid in the treatment of patients with MDR-TB

Crossref DOI link: https://doi.org/10.1016/j.pulmoe.2023.09.003

Published Online: 2025-03-10

Published Print: 2024-03-30

Update policy: https://doi.org/10.1080/tandf_crossmark_01

Authors

Oehadian, A. https://orcid.org/0000-0002-7853-2221
Bastos, M.L.

Centis, R.

D'Ambrosio, L.

Migliori, G.B. https://orcid.org/0000-0002-2597-574X
Santoso, P. https://orcid.org/0000-0002-7182-386X
Ruslami, R. https://orcid.org/0000-0003-4995-5054
Menzies, D.
License Information

Version of Record valid from 2024-03-30
More Information

Peer Review Statement: The publishing and review policy for this title is described in its Aims & Scope.

Aim & Scope: http://www.tandfonline.com/action/journalInformation?show=aimsScope&journalCode=tpul20

Publication History

Received: 2023-08-19

Accepted: 2023-09-13

Published: 2025-03-10